Tiaa, Fsb Viatris Inc Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Viatris Inc stock. As of the latest transaction made, Tiaa, Fsb holds 13,361 shares of VTRS stock, worth $171,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,361

Previous 15,156 11.84%

Holding current value

$171,421

Previous $145,000 8.28%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$9.02 - $10.29 $16,190 - $18,470	-1,795 Reduced 11.84%	13,361 $133,000
Q1 2023 Apr 19, 2023	SELL	$9.2 - $12.26 $34,058 - $45,386	-3,702 Reduced 19.63%	15,156 $145,000
Q4 2022 Jan 12, 2023	BUY	$8.72 - $11.56 $24,860 - $32,957	2,851 Added 17.81%	18,858 $210,000
Q3 2022 Oct 11, 2022	SELL	$8.48 - $11.13 $30,197 - $39,633	-3,561 Reduced 18.2%	16,007 $136,000
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $26,019 - $32,086	-2,615 Reduced 11.79%	19,568 $205,000
Q1 2022 Apr 13, 2022	SELL	$9.81 - $15.4 $68,316 - $107,245	-6,964 Reduced 23.89%	22,183 $241,000
Q4 2021 Feb 01, 2022	SELL	$12.09 - $14.68 $33,924 - $41,192	-2,806 Reduced 8.78%	29,147 $395,000
Q3 2021 Oct 14, 2021	SELL	$13.25 - $15.13 $89,874 - $102,626	-6,783 Reduced 17.51%	31,953 $432,000
Q2 2021 Jul 21, 2021	SELL	$12.97 - $16.15 $70,504 - $87,791	-5,436 Reduced 12.31%	38,736 $554,000
Q1 2021 Apr 21, 2021	SELL	$13.59 - $18.54 $325,331 - $443,829	-23,939 Reduced 35.15%	44,172 $616,000
Q4 2020 Jan 21, 2021	BUY	$14.3 - $18.74 $973,987 - $1.28 Million	68,111 New	68,111 $1.28 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account